PDCD1 and lymphoma: Here we demonstrate that treatment of EBV-infected cord-blood humanized NSG mice with the combination of both CTLA-4 and PD-1 blocking antibodies strikingly decreases the growth rate of EBV-induced lymphomas, and increases the length of survival in mice.